MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Excessive daytime sleepiness is mediated by loss of caudate dopaminergic function in Parkinson’s disease

T. Yousaf, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

Meeting: 2016 International Congress

Abstract Number: 1202

Keywords: Excessive daytime sleepiness(EDS)

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Neuroimaging and neurophysiology

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To investigate whether excessive daytime sleepiness (EDS) is mediated by loss of dopaminergic function by using dopaminergic specific single photon emission computed tomography (SPECT) molecular imaging in early de novo PD patients with and without EDS.

Background: EDS is one of the earliest and most debilitating non-motor symptoms of PD and often challenging to manage in the clinic. Preclinical investigations have demonstrated that dopamine depletion causes sleep disturbances, suggesting that dopamine may play a fundamental role in regulating the sleep-wake cycle, hence potentially underlie EDS pathogenesis.

Methods: We performed a case-control study using the Parkinson’s Progression Markers Initiative database, where we assessed and compared semi-quantified [123I]FP-CIT SPECT, and motor and non-motor features from two groups of 84 early de novo PD patients with and without EDS who were matched for age, gender, age of diagnosis, years of education and disease duration. We also explored clinical and imaging correlates of EDS and the predictive significance of these markers in the development of EDS in PD patients without EDS.

Results: PD patients with EDS had worse non-motor (MDS-UPDRS part I, p<0.001; MDS-UPRDS part II, p=0.005), autonomic (SCOPA-AUT, p<0.0001) and cognitive (MoCA, p=0.05) function, depression (GDS, P=0.001), and reduced caudate dopamine transporters ([123I]FP-CIT, p=0.024) compared to PD patients without EDS. Lower caudate [123I]FP-CIT values correlated with higher EDS scores (r2=0.037, p=0.013). Among patients without EDS, 47 PD patients (56%) developed EDS over a median follow-up of 36 months. Cox multivariate analysis including all clinical and imaging data available, revealed abnormal caudate [123I]FP-CIT uptake (p=0.030) and disease duration (p=0.018) were predictors for the development of EDS.

Conclusions: Our data provides novel insight that loss of caudate dopaminergic function is associated with EDS severity and susceptibility. Impairment of dopaminergic function within the caudate should be further investigated to confirm its role in regulating the sleep-wake cycle.

To cite this abstract in AMA style:

T. Yousaf, G. Pagano, F. Niccolini, M. Politis. Excessive daytime sleepiness is mediated by loss of caudate dopaminergic function in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/excessive-daytime-sleepiness-is-mediated-by-loss-of-caudate-dopaminergic-function-in-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/excessive-daytime-sleepiness-is-mediated-by-loss-of-caudate-dopaminergic-function-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley